AstraZeneca BioVentureHub – A unique industry-embedded innovation platform, for collaborations and growth within the life science industry
📅 Thursday 23 April, at 11:00am (CET)
Agenda
In this webinar, proposed by AstraZeneca BioVentureHub in collaboration with MabDesign, discover how innovative companies can unlock new opportunities to develop their technologies by collaborating closely with a leading global innovation player.
AstraZeneca BioVentureHub is a unique, industry-embedded innovation platform, located within the AZ R&D site in Gothenburg, Sweden, that enables emerging companies and academic groups to accelerate and de-risk their science alongside a global pharma partner.
By providing access to AstraZeneca’s scientific expertise, industry-grade facilities, collaboration opportunities, and a vibrant dare-to-share community, the hub offers a pragmatic bridge from university incubators to real-world industrial environments.
The focus is on increase technology exploration that accelerates drug development and advances sustainability. Participation is strictly independent, and AstraZeneca holds no ownership or innovation rights. In return, it allows AstraZeneca to explore novel science and technology.
Seize this unique opportunity to discover how AstraZeneca’s BioVentureHub can elevate your SME in the life science sector to new heights.
Speaker Biography
Pernilla Isberg, MSc, Director, AstraZeneca BioVentureHub
Pernilla Isberg is a pharmacist with 30 years of experience from working within AstraZeneca with marketing, clinical trials and cross functional project management. Since 2018 Pernilla is Director at AZ BioVentureHub, a novel approach to open innovation which allows emerging companies and academic groups to work in close proximity to the skills and capabilities that resides within big pharma. The focus is on challenges we can solve together.
